Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2012
07/05/2012WO2012091010A1 Bicyclic pyrimidine derivative
07/05/2012WO2012090043A1 Novel solid state forms of azilsartan medoxomil and preparation thereof
07/05/2012WO2012090005A1 Agonists of toll like receptor for treating cardiovasuclar disease and obesity
07/05/2012WO2012089137A1 Arylurea compound, intermediate and use thereof
07/05/2012WO2012088647A1 Deuterated acid addition salt of sitaliptin
07/05/2012WO2012088597A1 Nitric oxide amino acid esters for enhancement of physical or muscular performance and the treatment of muscular or neuromuscular diseases
07/05/2012WO2012088563A1 Vegfr-2-specific forms of vegf-d and vegf-c and uses thereof
07/05/2012WO2012064943A3 Metalloenzyme inhibitor compounds
07/05/2012WO2012048125A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
07/05/2012WO2012028622A3 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172448 Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof
07/05/2012US20120172431 Omega 3 fatty acid formulations
07/05/2012US20120172421 2, 6 xylidine derivatives for the treatment of pain
07/05/2012US20120172415 Exon Skipping Therapy for Functional Amelioration of Semifunctional Dystrophin in Becker and Duchenne Muscular Dystrophy
07/05/2012US20120172401 Benzimidazole derivative and use as angiotensin ii antagonist
07/05/2012US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172372 Ureas and Their Use in the Treatment of Heart Failure
07/05/2012US20120172363 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers
07/05/2012US20120172361 Triazine derivatives and their therapeutical applications
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/05/2012US20120172353 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172345 Heteroaryls and uses thereof
07/05/2012US20120172339 Angiogenic resorcinol derivatives
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172335 Substituted benzimidazolone derivatives, medicaments comprising them and their use
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120172320 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
07/05/2012US20120172307 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
07/05/2012US20120172306 Use of HASF as a Protective Agent Against Ischemic Tissue Damage
07/05/2012US20120172301 Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ace2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling
07/05/2012US20120172300 Remodeling and glycopegylation of fibroblast growth factor (fgf)
07/05/2012US20120172286 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis
07/05/2012US20120171765 Factor VII or VIIa - Like Molecules
07/05/2012US20120171315 Active substance for improving hyperlipidemia and hypercholesterolemia
07/05/2012US20120171307 Magnesium Compositions and Uses Thereof for Neurological Disorders
07/05/2012US20120171302 Compositions and methods for inhibiting redox-sensitive gtpases
07/05/2012US20120171288 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171274 Transdermal patch
07/05/2012US20120171262 Pharmaceutical formulations
07/05/2012US20120171259 Orally absorbed pharmaceutical formulation and method of administration
07/05/2012US20120171257 Cell-guiding fibroinductive and angiogenic scaffolds for periodontal tissue engineering
07/05/2012US20120171253 Fibromodulin Peptide
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171217 Monoclonal Antibodies Against ANGPTL4
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171194 Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy
07/05/2012US20120171180 Compositions comprising amnion derived adherent cells and platelet-rich plasma
07/05/2012US20120171161 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
07/05/2012US20120171150 Ion Bonding Pharmaceutical Composition
07/05/2012US20120171116 Arginase Inhibitors and Methods of Use Thereof
07/05/2012CA2817249A1 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
07/04/2012EP2471803A1 Compounds that interact with kinases
07/04/2012EP2471792A1 3-(biaryloxy) propionic acid derivative
07/04/2012EP2471782A1 Novel sulfonamide derivative and pharmaceutical product containing same
07/04/2012EP2471780A1 Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
07/04/2012EP2471777A1 Novel tetrahydroisoquinoline compounds
07/04/2012EP2471533A1 Aryl carbonyl derivatives as therapeutic agents
07/04/2012EP2471519A1 Controlled release formulation of carvedilol
07/04/2012EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
07/04/2012EP2470505A2 Polymorphic forms of manidipine
07/04/2012EP1874306B1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN1964703B Immediate release pharmaceutical tablets with height greater than width
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1882687B Method of growing myocardial cells
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN102548993A Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
07/04/2012CN102548985A Substituted carbonyl compounds
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102548573A Use of NKG2D inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
07/04/2012CN102548570A Compositions for the treatment of hemorrhoids and related diseases
07/04/2012CN102548566A Lactobacillus plantarum strains as hypocholesterolemic agents
07/04/2012CN102548560A Compositions and methods for prevention and treatment of coronary heart diseases
07/04/2012CN102548543A Slow-release cilostazol tablet having an improved elution rate and minimal side effects
07/04/2012CN102539466A Method for screening medicament for treating brain injury
07/04/2012CN102533972A IL1RL-1 as a cardiovascular disease marker and therapeutic target
07/04/2012CN102532345A O-unsaturated fatty acid acylated chitosan oligosaccharides as well as preparation and application thereof
07/04/2012CN102532265A Gramicidin, isomer thereof and application thereof
07/04/2012CN102532264A Peptide-based compounds
07/04/2012CN102532260A Silkworm chrysalis protein source dipeptide DA and uses thereof
07/04/2012CN102532207A N-unsaturated fatty acid acylated chitosan oligosaccharide and preparation and application thereof
07/04/2012CN102532163A Macrocyclic 4-amino-quinazoline derivatives and their use as MTKI
07/04/2012CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
07/04/2012CN102532134A Azaindoles useful as inhibitors of janus kinases
07/04/2012CN102532133A Azaindoles useful as inhibitors of janus kinases
07/04/2012CN102532123A Thiazole-5-methanamide compound and preparation method, medicinal composition and application thereof
07/04/2012CN102532114A Niacin derivative, preparation method thereof and medicine composition thereof
07/04/2012CN102532110A Quinazoline derivative and application of serving as cell apoptosis inhibitor
07/04/2012CN102532042A Aryl urea compound as well as intermediate and application thereof
07/04/2012CN102532033A Telmisartan salifying process
07/04/2012CN102531999A Amorphous lercanidipine hydrochloride and preparation method thereof
07/04/2012CN102531998A Alpha-type polymorphic clevidipine butyrate crystal and preparation method, application and pharmaceutical composition thereof
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 1595